2025 PRESENTER PROFILES
Cardiovascular Complications of Long Term Diabetes—Type 1 vs. Type 2
Monday, June 23, at 3:15 p.m. CT
Room W181 A-C • McCormick Place Convention Center
Getting Type 1 Diabetes Out from the Shadow of Type 2 Diabetes
Robert H. Eckel, MD
Physician-Scientist,
University of Colorado Anschutz Medical Campus
What is your presentation about?
Randomized cardiovascular outcome trials in patients living with diabetes have exclusively been implemented in patients living with type 2 diabetes. So why have such trials not been done in patients living with type 1 diabetes? To be discussed will be the rationale for this history, recommended steps to follow, and whether the science of atherosclerosis is different in type 1 diabetes and type 2 diabetes.
How do you hope your presentation will impact diabetes research or care?
The discussion will focus on what cardiovascular disease risk factors in patients with type 1 diabetes will be amenable to randomized controlled trials, and which risk factors might be unethical to consider and why. Risk factors that may be included will be glycemia (beyond the Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications (EDIC) study), excess body weight (adipose tissue), LDL cholesterol, blood pressure, coagulation, and inflammation.
How did you become involved with this area of diabetes research or care?
I’ve lived with type 1 diabetes for over 70 years.
